FEB 13, 2020 7:40 PM PST

Study of Early-Onset Parkinson's Reveals Potential Therapeutic

WRITTEN BY: Carmen Leitch

Around 500,000 Americans are diagnosed with Parkinson's disease every year, and the rate of the disease is rising. Symptoms include tremors, rigid muscles, slow movement, and loss of balance, which all get worse over time. The neurodegenerative disorder happens when neurons in the brain that make a signaling molecule called dopamine start malfunctioning or dying. The reason for that neuronal dysfunction and death is still unknown.

Image credit: Pixabay

New research reported in Nature Medicine has focused on the ten percent of Parkinson's patients that are diagnosed from the ages of 21 to 50, which is younger than typical patients, who tend to be diagnosed when they are over 60.

"Young-onset Parkinson's is especially heartbreaking because it strikes people at the prime of life," said study co-author Michele Tagliati, MD, director of the Movement Disorders Program, vice-chair, and professor in the Department of Neurology at Cedars-Sinai. "This exciting new research provides hope that one day we may be able to detect and take early action to prevent this disease in at-risk individuals."

The researchers applied the Nobel-prize winning technique for generating stem cells from adult blood cells for this work. They obtained the cells from the early-onset Parkinson's patients, then used the patient-derived induced pluripotent stem cells they created to make neurons that produce dopamine. They were then able to study these patient-derived cells in the lab to assess their physiology.

"Our technique gave us a window back in time to see how well the dopamine neurons might have functioned from the very start of a patient's life," noted the senior author of the study Clive Svendsen, Ph.D., director of the Cedars-Sinai Board of Governors Regenerative Medicine Institute and a professor of Biomedical Sciences and Medicine at Cedars-Sinai.

Two critical cellular abnormalities were identified by the scientists; a protein called alpha-synuclein was building up, which is similar to what's seen in Parkinson's disease, and cellular recycling centers known as lysosomes were not functioning properly. This lysosomal dysfunction may be causing alpha-synuclein accumulation.

"What we are seeing using this new model are the very first signs of young-onset Parkinson's," said Svendsen. "It appears that dopamine neurons in these individuals may continue to mishandle alpha-synuclein over a period of 20 or 30 years, causing Parkinson's symptoms to emerge."

The researchers also tested drugs using the cells they engineered to see if any could stop or reverse the dysfunctions. One drug called PEP005 that is already used to treat skin precancers was able to lower the high alpha-synuclein levels in the cells as well as in a mouse model.

The team wants to learn more about how this drug might be used to prevent or treat early-onset Parkinson's disease, and whether the abnormalities they identified hold true for other types of Parkinson's.

Sources: Science Daily via Cedars-Sinai Medical Center, Nature Medicine

About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
AUG 27, 2020
Cardiology
Are Dry Mouth and Hypertension Connected?
AUG 27, 2020
Are Dry Mouth and Hypertension Connected?
Dry mouth is one of those things you sort of ignore until you can refill your water bottle. Maybe you should take a seco ...
AUG 29, 2020
Cardiology
Protecting the Heart Against Damage from Mechanical Stress
AUG 29, 2020
Protecting the Heart Against Damage from Mechanical Stress
Heart failure is a traumatic event that can have long-lasting consequences. Often, after an adverse cardiac event, the h ...
SEP 11, 2020
Cell & Molecular Biology
How Variants Affect Gene Expression Across Cell Types
SEP 11, 2020
How Variants Affect Gene Expression Across Cell Types
The Genotype-Tissue Expression (GTEx) Consortium, has produced multiple papers that have provided new insight into human ...
OCT 18, 2020
Cell & Molecular Biology
Small RNA is Connected to Bacterial Pathogenicity
OCT 18, 2020
Small RNA is Connected to Bacterial Pathogenicity
It's thought that as much as half of the global population carries a bacterium called Helicobacter pylori in their stoma ...
OCT 21, 2020
Cell & Molecular Biology
Extracellular Vesicles Help Heart Cells Survive a Heart Attack
OCT 21, 2020
Extracellular Vesicles Help Heart Cells Survive a Heart Attack
During a heart attack, blood flow is blocked and cells lose oxygen and begin to die. Scientists are developing many new ...
OCT 29, 2020
Cell & Molecular Biology
How Does the Immune System Handle the Microbiome?
OCT 29, 2020
How Does the Immune System Handle the Microbiome?
The human body plays host to trillions of microbes, and many of them live in our gastrointestinal tract; these microorga ...
Loading Comments...